Cardiovascular diseases remain the leading cause of death in Europe, yet the methods used to test new drugs are still outdated, slow, and often unreliable. After more than four years of dedicated research, the EU-funded EMAPS-Cardio project has concluded with a breakthrough that promises wide-reaching benefits for patients and society at large.
At the core of EMAPS-Cardio’s success is a laboratory-grown heart tissue to closely mimic the function of an adult human heart.
The platform enables earlier and more accurate detection of cardiotoxicity, reducing reliance on less accurate animal models and reducing the risk of costly late-stage drug failures.
To explore the project’s scientific journey and achievements, visit www.emaps-cardio.eu and watch the final video released by the team on YouTube.
Recent Comments